Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Jonsson

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Computer Methods and Programs in Biomedicine|April 9, 1999
Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEME N Jonsson, M O Karlsson
Pharmaceutical Research|October 2, 1998
Automated covariate model building within NONMEME N Jonsson, M O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|July 27, 2001
Assessment of actual significance levels for covariate effects in NONMEMU Wählby, E N Jonsson, M O Karlsson
Pharmaceutical Research|September 1, 1999
Likelihood-based diagnostics for influential individuals in non-linear mixed effects model selectionS Sadray, E N Jonsson, M O Karlsson
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1996
Comparison of some practical sampling strategies for population pharmacokinetic studiesE N Jonsson, J R Wade, M O Karlsson
AAPS Pharmsci|December 14, 2001
Nonlinearity detection: advantages of nonlinear mixed-effects modelingE N Jonsson, J R Wade, M O Karlsson
Pharmaceutical Research|August 1, 1997
Discrimination between rival dosing historiesE N Jonsson, J R Wade, G Almqvist, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 31, 1998
Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patientsM O Karlsson, E N Jonsson, C G Wiltse, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Comparisons of Analysis Methods for Proof-of-Concept TrialsK E Karlsson, C Vong, M Bergstrand, et al.
The Journal of Organic Chemistry|October 13, 2001
Probing sponge-derived terpenoids for human 15-lipoxygenase inhibitorsJ Carroll, E N Jonsson, R Ebel, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Computer Methods and Programs in Biomedicine|April 9, 1999
Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEME N Jonsson, M O Karlsson
Pharmaceutical Research|October 2, 1998
Automated covariate model building within NONMEME N Jonsson, M O Karlsson
Journal of Pharmacokinetics and Pharmacodynamics|July 27, 2001
Assessment of actual significance levels for covariate effects in NONMEMU Wählby, E N Jonsson, M O Karlsson
Pharmaceutical Research|September 1, 1999
Likelihood-based diagnostics for influential individuals in non-linear mixed effects model selectionS Sadray, E N Jonsson, M O Karlsson
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1996
Comparison of some practical sampling strategies for population pharmacokinetic studiesE N Jonsson, J R Wade, M O Karlsson
AAPS Pharmsci|December 14, 2001
Nonlinearity detection: advantages of nonlinear mixed-effects modelingE N Jonsson, J R Wade, M O Karlsson
Pharmaceutical Research|August 1, 1997
Discrimination between rival dosing historiesE N Jonsson, J R Wade, G Almqvist, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 31, 1998
Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patientsM O Karlsson, E N Jonsson, C G Wiltse, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Comparisons of Analysis Methods for Proof-of-Concept TrialsK E Karlsson, C Vong, M Bergstrand, et al.
The Journal of Organic Chemistry|October 13, 2001
Probing sponge-derived terpenoids for human 15-lipoxygenase inhibitorsJ Carroll, E N Jonsson, R Ebel, et al.
Pageof 2